Viscient Biosciences
Phase 2Viscient Biosciences is a biotechnology company focused on utilizing 3D tissue technology
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $50M
About
Viscient Biosciences is a biotechnology company focused on utilizing 3D tissue technology
Small Molecules
Funding History
2Total raised:$50M
Series B$35MMar 15, 2021
Series A$15MJun 15, 2019